|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/4045 | (2006.01) |
| (11) | Number of the document | 3030227 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14753182.6 |
| Date of filing the European patent application | 2014-08-06 | |
| (97) | Date of publication of the European application | 2016-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation | 2020-06-10 |
| (86) | Number | PCT/US2014/049940 |
| Date | 2014-08-06 |
| (87) | Number | WO 2015/021153 |
| Date | 2015-02-12 |
| (30) | Number | Date | Country code |
| 201361863325 P | 2013-08-07 | US | |
| 201361913066 P | 2013-12-06 | US |
| (72) |
YELESWARAM, Krishnaswamy, US
PARIKH, Bhavnish, US
MODI, Dilip P., US
SHETH, Trupti, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prailginto atpalaidavimo JAK1 inhibitoriaus dozavimo formos |
| SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-07-31 | 12 | 289.00 EUR |
| 2026-08-06 |